Onxol Alternatives Compared
Onxol | Enhertu | Trodelvy |
|
---|
Onxol (paclitaxel) | Enhertu (fam-trastuzumab deruxtecan) | Trodelvy (sacituzumab govitecan) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer, Kaposi's Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Wilms' Tumor. Onxol may also be used for purposes not... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Gastric Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Solid Tumors. Enhertu may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer, Urothelial Carcinoma. Trodelvy may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Onxol (paclitaxel) | More about Enhertu (fam-trastuzumab deruxtecan) | More about Trodelvy (sacituzumab govitecan) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Enhertu has an average rating of 7.9 out of 10 from a total of 21 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 5% reported a negative effect. |
Trodelvy has an average rating of 8.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Onxol side effects in more detail. |
See also: Enhertu side effects in more detail. |
See also: Trodelvy side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic approved |
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Enhertu prices |
View all Trodelvy prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
17.4 hours |
136.8 hours |
18 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 490 drugs are known to interact with Onxol:
|
A total of 165 drugs are known to interact with Enhertu:
|
A total of 112 drugs are known to interact with Trodelvy:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.